Gotham Asset Management’s ICU Medical ICUI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.85M | Buy |
29,820
+5,080
| +21% | +$730K | 0.01% | 929 |
|
|
2025
Q4 | $3.53M | Sell |
24,740
-16,300
| -40% | -$2.18M | 0.01% | 892 |
|
|
2025
Q3 | $4.92M | Buy |
41,040
+12,019
| +41% | +$1.52M | 0.02% | 783 |
|
|
2025
Q2 | $3.84M | Buy |
29,021
+6,768
| +30% | +$918K | 0.02% | 738 |
|
|
2025
Q1 | $3.09M | Sell |
22,253
-18,357
| -45% | -$2.85M | 0.03% | 661 |
|
|
2024
Q4 | $6.3M | Buy |
40,610
+7,410
| +22% | +$1.25M | 0.06% | 448 |
|
|
2024
Q3 | $6.05M | Buy |
33,200
+15,966
| +93% | +$2.36M | 0.06% | 434 |
|
|
2024
Q2 | $2.05M | Buy |
17,234
+7,924
| +85% | +$834K | 0.03% | 674 |
|
|
2024
Q1 | $999K | Buy |
+9,310
| New | +$926K | 0.02% | 850 |
|
|
2022
Q2 | – | Sell |
-4,290
| Closed | -$955K | – | 1179 |
|
|
2022
Q1 | $955K | Sell |
4,290
-1,195
| -22% | -$268K | 0.03% | 577 |
|
|
2021
Q4 | $1.3M | Buy |
5,485
+4,606
| +524% | +$1.08M | 0.04% | 475 |
|
|
2021
Q3 | $205K | Sell |
879
-1,220
| -58% | -$256K | 0.01% | 965 |
|
|
2021
Q2 | $432K | Sell |
2,099
-98
| -4% | -$20.2K | 0.02% | 729 |
|
|
2021
Q1 | $451K | Buy |
+2,197
| New | +$464K | 0.02% | 703 |
|
|
2019
Q1 | – | Sell |
-11,720
| Closed | -$2.69M | – | 1199 |
|
|
2018
Q4 | $2.69M | Sell |
11,720
-43,386
| -79% | -$10.7M | 0.04% | 435 |
|
|
2018
Q3 | $15.6M | Buy |
55,106
+3,139
| +6% | +$919K | 0.22% | 145 |
|
|
2018
Q2 | $15.3M | Sell |
51,967
-30,064
| -37% | -$8.22M | 0.22% | 140 |
|
|
2018
Q1 | $20.7M | Buy |
82,031
+39,245
| +92% | +$9.22M | 0.29% | 110 |
|
|
2017
Q4 | $9.24M | Buy |
+42,786
| New | +$8.66M | 0.13% | 231 |
|
|
2017
Q3 | – | Sell |
-5,259
| Closed | -$907K | – | 972 |
|
|
2017
Q2 | $907K | Sell |
5,259
-15,624
| -75% | -$2.51M | 0.01% | 649 |
|
|
2017
Q1 | $3.19M | Sell |
20,883
-11,215
| -35% | -$1.64M | 0.04% | 475 |
|
|
2016
Q4 | $4.73M | Sell |
32,098
-23,276
| -42% | -$3.37M | 0.06% | 390 |
|
|
2016
Q3 | $7M | Buy |
55,374
+13,845
| +33% | +$1.67M | 0.09% | 301 |
|
|
2016
Q2 | $4.68M | Buy |
41,529
+934
| +2% | +$96.9K | 0.06% | 399 |
|
|
2016
Q1 | $4.23M | Sell |
40,595
-1,570
| -4% | -$150K | 0.05% | 463 |
|
|
2015
Q4 | $4.75M | Sell |
42,165
-15,087
| -26% | -$1.67M | 0.05% | 426 |
|
|
2015
Q3 | $6.27M | Sell |
57,252
-163,826
| -74% | -$17.5M | 0.06% | 390 |
|
|
2015
Q2 | $21.1M | Buy |
221,078
+108,428
| +96% | +$10.1M | 0.18% | 194 |
|
|
2015
Q1 | $10.5M | Sell |
112,650
-1,770
| -2% | -$155K | 0.08% | 336 |
|
|
2014
Q4 | $9.37M | Sell |
114,420
-4,106
| -3% | -$315K | 0.08% | 332 |
|
|
2014
Q3 | $7.61M | Sell |
118,526
-105,585
| -47% | -$6.47M | 0.08% | 334 |
|
|
2014
Q2 | $13.6M | Sell |
224,111
-18,510
| -8% | -$1.09M | 0.17% | 195 |
|
|
2014
Q1 | $14.5M | Buy |
242,621
+109,088
| +82% | +$6.72M | 0.22% | 160 |
|
|
2013
Q4 | $8.51M | Buy |
+133,533
| New | +$8.59M | 0.2% | 167 |
|
Other funds holding ICUI
VPM
VCM
RRAM
Gotham Asset Management's ICUI Position: Q1 2026 in Review
Gotham Asset Management increased its ICU Medical (ICUI) stake by 21% in Q1 2026, buying an estimated $730K and bringing the position to 29,820 shares worth $3.85M. The position accounts for 0.01% of the portfolio, ranked #929.
Gotham Asset Management first reported a position in ICUI in Q4 2013 and has held it in 34 quarters since. The position peaked at $21.1M in Q2 2015. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.
- Gotham Asset Management held 29,820 shares of ICU Medical worth $3.85M as of Q1 2026.
- Gotham Asset Management bought 5,080 ICU Medical shares in Q1 2026, an estimated $730K.
- ICU Medical made up 0.01% of Gotham Asset Management's portfolio in Q1 2026, its #929 holding.
- Gotham Asset Management first reported a position in ICU Medical in Q4 2013 and has held it in 34 quarters since.
- Gotham Asset Management's ICU Medical position peaked at $21.1M in Q2 2015.
- 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.
Based on Gotham Asset Management's 13F filing for Q1 2026, filed 15 May 2026.